Insys Announces Details of Product Development Pipeline

PHOENIX, AZ–(Marketwired – Jan 13, 2014) –  Insys Therapeutics, Inc. (NASDAQ: INSY) today unveiled details of its portfolio pipeline, focused on innovative supportive care and therapy products. The Company intends to file one New Drug Application (NDA) and at least three Investigational New Drug (IND) applications with the Food and Drug Administration (FDA) in 2014.Continue reading